Healthcare >> Analyst Interviews >> October 17, 2003
DAVID E. WOOD is a Senior Biotechnology Analyst at Rodman & Renshaw.
Prior to joining Rodman, Dr. Wood was an analyst in Stephens Inc's.
equity research department. He earned his PhD in molecular oncology and
immunology studying the molecular mechanism of chemotherapy-induced
apoptosis of leukemia cells. In addition, Dr. Wood carried out
postdoctoral training at Children's Hospital/Harvard Medical School
studying gene expression in Alzheimer's disease. He earned his PhD from
New York University School of Medicine and his BA in Biology from
Bowdoin College. Profile
Mr. Wood: I joined Rodman & Renshaw about three months ago and have been
developing a coverage list that will focus on companies
